Clinical Trial Update: Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG) [NA]

View source ↗

Summary

A completed clinical trial compared Cosopt with Combigan for retinal vascular autoregulation in primary open-angle glaucoma. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)
• Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Glaucoma | NA | Status: COMPLETED | Results posted: 2016-10-28